Butterfly Peas Bloom in Snacks: FDA's Colorful Approval
Published Date: 5/12/2025
Rule
Summary
The FDA just gave a thumbs-up to using butterfly pea flower extract as a natural color in snacks like cereals, chips, and pretzels. This means snack makers can now safely add this cool blue-purple color without extra certification, as long as they follow good manufacturing rules. Snack lovers and food companies get a fresh, fun look with no extra costs or delays!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Food Makers Allowed New Natural Color
The FDA amended color additive rules to allow the use of butterfly pea flower extract as a color additive exempt from certification in ready-to-eat cereals, crackers, snack mixes, hard pretzels, plain potato chips (restructured or baked), and plain corn, tortilla, and multigrain chips. Manufacturers may use it at levels consistent with good manufacturing practice (GMP).
Consumers May See New Blue‑Purple Snacks
You may start seeing butterfly pea flower extract used as a natural blue‑purple color in ready-to-eat cereals, crackers, snack mixes, hard pretzels, plain potato chips (restructured or baked), and plain corn, tortilla, and multigrain chips. The FDA cleared these uses as safe when used at levels consistent with good manufacturing practice (GMP).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10321 — Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.
2026-10295 — M11 Clinical Electronic Structured Harmonised Protocol (CeSHarP); International Council for Harmonisation; Guidance for Industry; Availability
The FDA just released a new, easy-to-use digital guide called M11 CeSHarP to help everyone involved in clinical trials share and review study plans faster and clearer. This affects drug companies, researchers, and regulators worldwide by setting a global standard for how trial info is written and shared electronically. The new rules kick in now, aiming to save time and reduce confusion, with no direct cost but big efficiency gains.
2026-10277 — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by July 21, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
2026-10268 — Notice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
The FDA decided not to add Hepatitis Delta Virus (HDV) to the list of tropical diseases because it doesn’t fully meet the rules about market size and who it affects. This means drug makers won’t get special priority review vouchers for HDV treatments right now. People working on HDV drugs should keep an eye out for future updates but won’t see changes or new incentives immediately.
2026-10190 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
The FDA is updating how companies ask for extra patent time when their new drugs or devices take a while to get approved. This affects drug and medical device makers who want to protect their inventions longer. Comments on these changes are open until June 22, 2026, and the update aims to keep the process clear without adding extra costs or delays.
Previous / Next Documents
Previous: 2025-08231 — Takes of Marine Mammals Incidental to Specified Activities; Taking Marine Mammals Incidental to the Lower Columbia River Dredged Material Management Plan, Oregon and Washington
The U.S. Army Corps of Engineers will dredge the Lower Columbia River from 2027 to 2032, and this plan lets them accidentally affect some marine mammals but in a careful way. Rules are set to protect these animals as much as possible, with strict monitoring and reporting. This means work can move forward while keeping marine life safe and sound.
Next: 2025-08249 — Listing of Color Additives Exempt From Certification; Calcium Phosphate
The FDA is giving a green light to use calcium phosphate as a color additive in ready-to-eat chicken, white candy melts, doughnut sugar, and coated candy sugar. This change helps food makers add safe color to these treats without extra costs or delays. If you’re in the food biz, get ready to brighten up your products with this new option!